Karyopharm Therapeutics, Inc. (KPTI)
6.25
-0.07
(-1.11%)
USD |
NASDAQ |
Jan 22, 12:49
Karyopharm Therapeutics Free Cash Flow: -89.30M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Bruker Corp. | -10.60M |
| IDEXX Laboratories, Inc. | 940.22M |
| TG Therapeutics, Inc. | -70.24M |
| Axsome Therapeutics, Inc. | -101.39M |
| Krystal Biotech, Inc. | 165.59M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.86M |
| Cash from Investing (Quarterly) | 4.805M |
| Free Cash Flow Per Share (Quarterly) | -0.676 |
| Free Cash Flow to Equity (Quarterly) | -11.66M |
| Free Cash Flow to Firm (Quarterly) | 5.159M |
| Free Cash Flow Yield | -167.3% |